SKI Market

A+| A| A-|

Indian Indices

Sensex

76,664.21 -999.79
( -1.29%)

Global Indices

Nasdaq

49,249.13 -82.20
(-0.17%)

Dow Jones

7,185.72 56.32
(0.79%)

Hang Seng

59,744.07 603.84
(1.02%)

Nikkei 225

10,387.94 -69.07
(-0.66%)

Forex

USD-INR

94.05 0.29
(0.31%)

EUR-INR

109.99 0.01
(0.01%)

GBP-INR

126.84 0.17
(0.14%)

JPY-INR

0.59 0.00
(0.16%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

17.34

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

244.67

55.97

EPS(TTM)

Face Value()

Div & Yield %

0.15

Back

Beardsell consolidated net profit declines 35.13% in the September 2025 quarter

Nov 17,2025

Net profit of Beardsell declined 35.13% to Rs 2.05 crore in the quarter ended September 2025 as against Rs 3.16 crore during the previous quarter ended September 2024. Sales rose 3.68% to Rs 71.01 crore in the quarter ended September 2025 as against Rs 68.49 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	71.01	68.49	4
OPM %	8.35	9.48	-
PBDT	5.63	5.98	-6
PBT	3.84	4.00	-4
NP	2.05	3.16	-35

76,664.21 -999.79 ( -1.29%)

49,249.13 -82.20 (-0.17%)

7,185.72 56.32 (0.79%)

59,744.07 603.84 (1.02%)

10,387.94 -69.07 (-0.66%)

94.05 0.29 (0.31%)

109.99 0.01 (0.01%)

126.84 0.17 (0.14%)

0.59 0.00 (0.16%)